Unlock instant, AI-driven research and patent intelligence for your innovation.

Organic selenium compound for preventing and treating cancer

A compound and composition technology, applied in the field of selenium-containing organic compounds, can solve problems such as side effects, anti-cancer efficacy to be further improved, and limited structure types of compounds

Active Publication Date: 2016-11-23
SHENZHEN F&S BIO TECH
View PDF3 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Surgical treatment methods are effective in removing cancer at an early stage, however, the disadvantage is that sometimes organs have to be removed, which causes side effects and has the uncertainty of cancer spreading to other organs
Radiation therapy is good for effectively treating cancers that occur in a specific organ, but has the following disadvantages: it exposes the patient to the risk of other cancers because of the radiation, it cannot prevent cancer cells from spreading to other organs, and the patient suffers a lot during treatment. pain of
[0008] Although the above-mentioned organic selenium compounds have been discovered, the existing organic selenium compounds still have problems such as anti-cancer efficacy to be further improved, limited anti-cancer spectrum, and limited structural types of compounds, which are far from meeting the growing demands of human beings for cancer prevention and treatment. needs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Organic selenium compound for preventing and treating cancer
  • Organic selenium compound for preventing and treating cancer
  • Organic selenium compound for preventing and treating cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0086] Example 1: phenylselenoate 2-acetoxybenzoate

[0087] The reaction formula is as follows:

[0088]

[0089] Add phenylselenium chloride (1.51 g, 6.67 mmol) and 20 ml of anhydrous dichloromethane into a 50 ml flask, cool to -15°C in an ice-salt bath and stir, then add tributylphosphine (1.12 g, 5.56 mmol), 2-acetyl Oxybenzoic acid (1.00 g, 5.56 mmol) was protected by high-purity argon, kept at -15°C and stirred for 2.0 hours, and the reaction was complete as monitored by TLC. The solvent was distilled off under reduced pressure, separated by silica gel column chromatography, and ethyl acetate (V): Petroleum ether (V)=1:20 was used as the mobile phase to obtain 1.1 g of white needle-like crystals with a yield of 61%.

[0090] nuclear magnetic resonance 1 H NMR (400MHz, CDCl 3 ): 2.33 (s, 3H, CH 3 ), 7.16 (d, J = 8.00 Hz,1H, ArH), 7.35-7.43 (m, 4H, ArH), 7.56-7.59 (m, 3H, ArH), 7.97 (d, J = 8.00Hz, 1H, ArH ). 13 C NMR (100Hz, CDCl 3 ): 21.4, 124.3, 126.5, 129.3, ...

Embodiment 2

[0092] Example 2: 2-(4-isobutylphenyl)-phenylselenopropionate

[0093] The reaction formula is as follows:

[0094]

[0095] Add phenylselenide chloride (0.77g, 4.04 mmol) and 30ml of anhydrous dichloromethane into a 50ml flask, cool to -15°C in an ice-salt bath and stir, then add tributylphosphine (0.82g, 4.04 mmol), 2-( 4-Isobutylphenyl)-propionic acid (0.50g, 2.69mmol), passed through high-purity argon protection, kept stirring at -15°C for 2.0 hours, TLC monitored that the reaction was complete, distilled off the solvent under reduced pressure, and the silica gel column layer Analysis and separation, using ethyl acetate (V): petroleum ether (V) = 1:20 as the mobile phase, to obtain 0.72 g of colorless oily liquid II, with a yield of 74%.

[0096] nuclear magnetic resonance 1 H NMR (400MHz, CDCl 3 ): 0.90 (s, 3H, CH 3 ), 0.92 (s, 3H, CH 3 ), 1.55(d, J = 8.00 Hz, 3H, CH 3 ), 1.85 (m, 1H, CH), 2.48 (d, 2H, CH 2 ), 3.96 (q, J =8.00 Hz, 1H, CH), 7.14(d, J = 8.00 Hz, 2...

Embodiment 3

[0098] Example 3: (+)-α-Methyl-6-methoxy-2-naphthalene phenylselenoacetate

[0099] The reaction formula is as follows:

[0100]

[0101] Add phenylselenium bromide (0.77 g, 3.26 mmol) and 20 ml of anhydrous tetrahydrofuran into a 50 ml flask, cool to -15°C in an ice-salt bath and stir, then add tributylphosphine (0.88 g, 4.34 mmol), (+)-α -Methyl-6-methoxy-2-naphthaleneacetic acid (0.50g, 2.17 mmol), passed through high-purity argon protection, kept stirring at -15°C for 3.0 hours, TLC monitored the reaction was complete, and distilled off the solvent under reduced pressure, Separation by silica gel column chromatography, using ethyl acetate (V):petroleum ether (V)=1:8 as the mobile phase, afforded 0.66 g of white solid III with a yield of 83%.

[0102] nuclear magnetic resonance 1 H NMR (400MHz, CDCl 3 ): 1.63 (d, J = 8.00 Hz, 3H, CH 3 ), 3.92 (s,3H,CH 3 ), 4.12 (q, J = 8.00 Hz, 1H, CH), 7.14-7.18 (m, 2H, ArH), 7.30-7.34 (m,3H, ArH), 7.39-7.43 (m, 3H, ArH), 7.73 -7....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a compound for preventing and treating cancer. The structure formula of the compound is formula (I) as follows: Ar1-A-C(M)-Se-Ar2, wherein A, Ar1, Ar2 and M are defined in claims. The invention also provides a preparation method of the compound with the formula (I) and a pharmaceutical composition comprising the compound with the formula (I).

Description

technical field [0001] The application relates to a selenium-containing organic compound for preventing and treating cancer, a preparation method of the compound and a pharmaceutical composition containing the compound. Background technique [0002] Cancer is the leading cause of disease and death worldwide and is expected to continue to increase as modern technologies increase life expectancy. During the life of a cell, small changes to DNA called "mutations" occasionally occur. Of these mutations, some mutations (called "silent mutations") do not cause any substantial change in the function of the cell, while others alter the way the cell functions. Multiple mechanisms prevent mutated cells from continuing the cell cycle, and if the genetic error is not corrected, the cells "suicide" through a process known as "apoptosis." However, if mutations occur in proteins involved in cell cycle regulation, this can lead to uncontrolled cell proliferation (known as tumor formatio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C391/02C07D209/28A61K31/235A61K31/405A61P35/00
CPCC07C391/02C07D209/28
Inventor 贺贤然
Owner SHENZHEN F&S BIO TECH